COPD

Data showed that patients coming to the world-famous hospital for a heart attack grew younger, sicker, and more obese from 1995 to 2014. Because the researchers have not yet reported socioeconomic status, it is hard to know whether the findings reflect broader trends.

What we're reading, March 23, 2016: moderate alcohol consumption may not have any health benefits; Johnson & Johnson researching the development of 2 diseases; and 2 more California hospitals received ransom demands from hackers.

Patients can be shielded from the most onerous cost-sharing burdens for specialty drugs while keeping premiums affordable for the entire enrolled population.

Factors determining access to care are closely associated with hospital and emergency department visits among adults with chronic obstructive pulmonary disease.

Study finds no statistically significant duration in the use of mechanical ventilation for patients with chronic obstructive pulmonary disease who took acetazolamide, but there was a clinically significant difference.

In a nationwide cross-sectional comparison of organizational structure for chronic disease management, less attention was given to chronic obstructive pulmonary disease than chronic heart failure.

The presence of interstitial lung abnormalities is linked to an increased risk of death, according to a new research published in JAMA.

While patients with chronic obstructive pulmonary disease have a higher risk of stroke than the general population, patients who have frequent exacerbations of their illness actually have a reduced risk of stroke than those with infrequent exacerbations.

Study finds new opioid use high among adults with COPD, raising safety concerns in this vulnerable population.

Proactive identification of cognitive impairment and compensatory destigmatized patient/familial psychoeducation regarding “forgetfulness” in hospitalized patients with congestive heart failure may reduce readmission rates substantially.

Patient-reported symptoms in chronic obstructive pulmonary disease may contribute information that can be used to infer future exacerbations and related costs.

An individualized comprehensive care package for acute exacerbation of chronic obstructive pulmonary disease patients reduces 90-day mortality.

All-cause mortality in patients with chronic obstructive pulmonary disease is improved by a high level of continuity of care.

Patients with chronic conditions, such as chronic obstructive pulmonary disease, often have high-cost health needs that make choosing a health plan difficult.

Although, data on predictive risk factors for chronic obstructive pulmonary disease has been limited until now, researchers from the United Kingdom recently developed a model for predicting exacerbation risk using data obtainable from primary care.

Expanding and more representative participation in Medicare's Bundled Payments for Care Improvement initiative suggests potential for large impact, pending the results of risk-bearing participants.

Using information in a patient's electronic medical record during outpatient visits for patients with chronic obstructive pulmonary disease can lead to better outcomes, according to a study in Respiratory Medicine.

This week in managed care, The American Journal of Managed Care celebrated 20 years and presented its first Emerging Leader award, plus confusion reigns after study links processed meats to cancer and death rates on the decline.

Novartis' dual combination bronchodilator Utibron Neohaler inhalation powder for patients with chronic obstructive pulmonary disease (COPD) has received FDA approval. It is not indicated to treat asthma or sudden symptoms of COPD.

By enrolling selected high-risk elderly patients into the intervention, then empowering and educating them, this study successfully reduced hospital readmission rates.

While the age-standardized death rate for all causes of death combined, as well as heart disease, cancer, stroke, unintentional injuries, and diabetes, have slowed from 1969 to 2013, the rate for chronic obstructive pulmonary disease actually increased.

Despite the fact that post-bronchodilator spirometry is required for the diagnosis of chronic obstructive pulmonary disease, an analysis of primary care clinics found only 19% of patients diagnosed with the disease had undergone spirometry testing.

Three important patient-reported outcomes can help predict hospitalizations among patients with chronic obstructive pulmonary disease, potentially helping clinicians to categorize patients' level of risk and design preventive interventions and proper care.

Two head-to-head trials comparing the safety of Incruse Ellipta to 2 available bronchodilator treatments used by patients with chronic obstructive pulmonary disease has yielded positive results for GlaxoSmithKline's therapy.

Researchers have found a high number of older adults with chronic obstructive pulmonary disease are using opioids excessively even though the drug may negatively effect lung health, according to a new study.

Integrated Medicare and Medicaid managed care may not sufficiently address the problems of inefficiency and fragmentation in care for hospitalized dual eligible enrollees.

Many individuals with chronic obstructive pulmonary disease (COPD) are only diagnosed after they experience late-stage exacerbations, but a new tool could hasten the process of diagnosing cases of COPD.

The use of telemedicine could be an alternative to visits at respiratory outpatient clinics for patients with severe chronic obstructive pulmonary disease, according to a study published in the International Journal of COPD.

Researchers in China and the United States have developed a predictive model capable of forecasting which patients will account for either small or large proportions of healthcare resource utilization in the next 6 months.

The path to President Obama's Precision Medicine Initiative has been paved as is evident from a report released by a Working Group convened by the National Institutes of Health.